Nicholas W. Choong
65 works · 3,922 citations · h-index 21
Top works
- Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
- Small cell carcinoma of the urinary bladder
- Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study
- Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation
- Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer
- Complete and Durable Response of Choroid Metastasis from Non-small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy
- Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy
- Therapeutic targeting of receptor tyrosine kinases in lung cancer
- Intramural Gastric AbscessCase History and Review
- EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
- Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia
- Phase I Trial of Erlotinib-Based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer
- Extended follow-up results of phase Ib study (BRIM7) of vemurafenib (VEM) with cobimetinib (COBI) in BRAF-mutant melanoma.
- Phase IB Study of Vemurafenib in Combination with the Mek Inhibitor, GDC-0973, in Patients (PTS) with Unresectable or Metastatic BRAFV600 Mutated Melanoma (BRIM7)
- Epidermal growth factor receptor directed therapy in head and neck cancer
- Vemurafenib and Cobimetinib Potently Inhibit Ps6 Signaling in Brafv600 Mutation–Positive Locally Advanced or Metastatic Melanoma from Brim7 Study
- Phase II study of sunitinib malate in head and neck squamous cell carcinoma
- Morbidities of lung cancer surgery in obese patients
- Continuous-Course Reirradiation With Concurrent Carboplatin and Paclitaxel for Locally Recurrent, Nonmetastatic Squamous Cell Carcinoma of the Head-and-Neck
- Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia